High Acceptability of a Vaginal Ring Intended as a Microbicide Delivery Method for HIV Prevention in African Women

被引:75
|
作者
van der Straten, A. [1 ,2 ]
Montgomery, E. T. [1 ]
Cheng, H. [1 ]
Wegner, L. [1 ]
Masenga, G. [3 ]
von Mollendorf, C. [4 ]
Bekker, L. [5 ,6 ]
Ganesh, S. [7 ]
Young, K. [8 ]
Romano, J. [9 ]
Nel, A. [8 ]
Woodsong, C. [8 ]
机构
[1] RTI Int, Womens Global Hlth Imperat, San Francisco, CA 94104 USA
[2] Univ Calif San Francisco, Ctr AIDS Prevent Studies, Dept Med, San Francisco, CA USA
[3] Kiliminjaro Christian Med Ctr, Moshi, Tanzania
[4] Wits Reprod Hlth & HIV Res Inst, Johannesburg, South Africa
[5] Univ Cape Town, ZA-7925 Cape Town, South Africa
[6] Desmond Tutu HIV Fdn, Cape Town, South Africa
[7] S African MRC, Durban, South Africa
[8] Int Partnership Microbicides, Paarl, South Africa
[9] NWJ Grp LLC, Wayne, PA USA
关键词
Vaginal ring; Microbicide; HIV/STI prevention; Acceptability; Africa; INTRAVAGINAL RINGS; CONTRACEPTIVE USE; SAFETY;
D O I
10.1007/s10461-012-0215-0
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Vaginal rings (VRs) are new methods for continuous delivery of microbicides. This is the first study to quantitatively and qualitatively explore the acceptability of rings in Africa: 157 HIV-negative, sexually active women aged 18-35 used a placebo silicone elastomer ring for 12 weeks. They completed product acceptability questionnaires every 4 weeks. We conducted 6 exit focus group discussions with a subset of 48 women and 19 in-depth interviews with male partners. Retention in the study was high (97 %). Initial insertion at the clinic was successful on first attempt for 81 % of participants. Most women were comfortable using the ring, and very few (a parts per thousand currency sign2 %) could feel it during daily activities or had ring-related physical or emotional problems. In the qualitative interviews many participants reported that they initially had concerns about using the ring. However, only a minority of women actually reported concerns with the ring during the study. The most frequent concern was that the ring would get lost inside the body (20 %), and this was significantly correlated with study site, frequently thinking about the ring and reporting that the ring was not very easy to remove. Qualitative data suggest that informants grew to like the ring because it felt securely placed, was unnoticeable during daily activities, and felt "normal" during sex. The ring appeared to be highly acceptable for women and men. Initial concerns with this novel method suggest a need for enhanced product counseling when VRs are introduced.
引用
收藏
页码:1775 / 1786
页数:12
相关论文
共 50 条
  • [21] Acceptability of the Dapivirine Vaginal Ring in Postmenopausal US Women
    Shapley-Quinn, Mary Kate
    Laborde, Nicole
    Luecke, Ellen
    Hoesley, Craig
    Salata, Robert A.
    Johnson, Sherri
    Nel, Annalene
    Soto-Torres, Lydia
    Chen, Beatrice A.
    van der Straten, Ariane
    AIDS PATIENT CARE AND STDS, 2022, 36 (03) : 97 - 105
  • [22] Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial
    Ashley J. Mayo
    Erica N. Browne
    Elizabeth T. Montgomery
    Kristine Torjesen
    Thesla Palanee-Phillips
    Nitesha Jeenarain
    Linly Seyama
    Kubashni Woeber
    Ishana Harkoo
    Krishnaveni Reddy
    Tchangani Tembo
    Prisca Mutero
    Thelma Tauya
    Miria Chitukuta
    Brenda Gati Mirembe
    Lydia Soto-Torres
    Elizabeth R. Brown
    Jared M. Baeten
    Ariane van der Straten
    AIDS and Behavior, 2021, 25 : 2430 - 2440
  • [23] High acceptability of a contraceptive vaginal ring among women in Kigali, Rwanda
    Kestelyn, Evelyne
    Van Nuil, Jennifer Ilo
    Umulisa, Marie Michelle
    Umutoni, Grace
    Uwingabire, Alice
    Mwambarangwe, Lambert
    Uwineza, Mireille
    Agaba, Stephen
    Crucitti, Tania
    van de Wijgert, Janneke
    Delvaux, Therese
    PLOS ONE, 2018, 13 (06):
  • [24] Acceptability of and Adherence to an Antiretroviral-Based Vaginal Microbicide among Pregnant Women in the United States
    Montgomery, Elizabeth T.
    Noguchi, Lisa M.
    Dai, James Y.
    Pan, Jason
    Biggio, Joseph
    Hendrix, Craig
    Isaacs, Karen
    Watts, D. Heather
    Schwartz, Jill L.
    Piper, Jeanna
    Beigi, Richard
    AIDS AND BEHAVIOR, 2018, 22 (02) : 402 - 411
  • [25] Preformulation and Vaginal Film Formulation Development of Microbicide Drug Candidate CSIC for HIV Prevention
    Gong, Tiantian
    Zhang, Wei
    Parniak, Michael A.
    Graebing, Phillip W.
    Moncla, Bernard
    Gupta, Phalguni
    Empey, Kerry M.
    Rohan, Lisa C.
    JOURNAL OF PHARMACEUTICAL INNOVATION, 2017, 12 (02) : 142 - 154
  • [26] Correlates of Adherence to the Dapivirine Vaginal Ring for HIV-1 Prevention
    Husnik, Marla J.
    Brown, Elizabeth R.
    Dadabhai, Sufia S.
    Gaffoor, Zakir
    Jeenarain, Nitesha
    Kiweewa, Flavia Matovu
    Livant, Edward
    Mansoor, Leila E.
    Mirembe, Brenda Gati
    Palanee-Phillips, Thesla
    Singh, Devika
    Siva, Samantha
    Soto-Torres, Lydia
    van der Straten, Ariane
    Baeten, Jared M.
    AIDS AND BEHAVIOR, 2021, 25 (09) : 2801 - 2814
  • [27] Acceptability and adherence of a candidate microbicide gel among high-risk women in Africa and India
    Bayer, Angela M.
    Tsui, Amy O.
    Hindin, Michelle J.
    CULTURE HEALTH & SEXUALITY, 2010, 12 (07) : 771 - 782
  • [28] Understanding Women's Vaginal Douching Behaviors and Practices for Consideration in the Development of a Potential Future Vaginal Microbicide Douche for HIV Prevention: A Systematic Review of the Literature
    Rael, Christine Tagliaferri
    Das, Doyel
    Bauermeister, Jose
    Lentz, Cody
    Carballo-Dieguez, Alex
    Giguere, Rebecca
    Scott, Rachel K.
    Hendrix, Craig W.
    AIDS AND BEHAVIOR, 2021, 25 (09) : 2992 - 3010
  • [29] Impact of Women's Home Environment on Use of the Dapivirine Vaginal Ring for HIV Prevention in Sub-Saharan Africa
    Gichane, Margaret W.
    Katz, Ariana W. K.
    Ngure, Kenneth
    Scheckter, Rachel
    Woeber, Kubashni
    Reddy, Krishnaveni
    Tauya, Thelma
    Zimba, Chifundo
    Etima, Juliane
    Mangxilana, Nomvuyo
    Palanee-Phillips, Thesla
    van der Straten, Ariane
    AIDS AND BEHAVIOR, 2021, 25 (12) : 3847 - 3857
  • [30] Participant experiences with a multipurpose vaginal ring for HIV and pregnancy prevention during a phase 1 clinical trial: learning from users to improve acceptability
    Shapley-Quinn, Mary Kate
    Song, Mei
    Chen, Beatrice A.
    Devlin, Brid
    Luecke, Ellen
    Brown, Jill
    Blithe, Diana L.
    Achilles, Sharon L.
    van der Straten, Ariane
    FRONTIERS IN REPRODUCTIVE HEALTH, 2023, 5